Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and activating brain appetite centers, leading to reduced hunger and lower calorie intake. Most patients begin losing weight within the first month, though individual timelines vary based on starting dose, metabolism, and lifestyle factors. Understanding realistic expectations helps you stay committed to your treatment plan.

When Does Semaglutide Start Working for Weight Loss?

Semaglutide begins affecting appetite regulation within days of your first injection, but noticeable weight loss typically appears between weeks 2 and 4. Early changes often include reduced food cravings, smaller portion sizes, and feeling fuller faster—signs that the medication is working at the cellular level. These appetite changes usually precede the scale moving downward.

By week 8, most patients report steady weekly weight loss ranging from 0.5 to 2 pounds, depending on adherence and dietary habits. Clinical trials show that participants using semaglutide lost an average of 10–15% of body weight over 68 weeks, with the steepest weight loss occurring between months 2 and 6. Your individual rate depends on factors like starting weight, age, physical activity, and how your genetics influence peptide sensitivity.

Monthly Weight Loss Expectations on Semaglutide Therapy

Month 1 typically brings 2–5 pounds of weight loss as your body adjusts to reduced calorie intake. This initial phase establishes new eating patterns and helps you recognize appetite signals. Some patients experience rapid water weight loss alongside fat loss during this period.

Months 2–3 often show accelerated results, with cumulative losses reaching 8–15 pounds as your dose stabilizes. By month 4–6, many patients achieve 15–25 pounds of total weight loss. After 6 months, weight loss may slow slightly as your body adapts, but continued progress typically continues through month 12 and beyond with consistent therapy and lifestyle support.

Factors That Influence Semaglutide Weight Loss Speed

Your genetic makeup plays a significant role in how quickly you respond to semaglutide. Variations in the GLP1R gene (like rs6923761) and the GIPR gene (rs1800437) affect how your body processes and responds to GLP-1 receptor agonists. PlexusDx Precision Peptide Genetic Test identifies these markers for $99, helping predict your individual response pattern and optimize your treatment from day one.

Diet quality, exercise frequency, sleep duration, and baseline metabolic rate all accelerate or slow weight loss progress. Patients who combine semaglutide with consistent calorie reduction and 150+ minutes of weekly activity lose weight faster than those relying on medication alone. Stress levels and medication adherence—taking injections on schedule each week—directly correlate with sustained results over 3–12 months.

PlexusDx Compounded Semaglutide: Affordable Access to Proven Results

PlexusDx delivers pharmaceutical-grade semaglutide from licensed 503A compounding pharmacies to all 50 states, requiring no insurance or membership fees. Starting at $149 per month, compounded semaglutide injections provide the same active ingredient as brand-name options at a fraction of the cost. Your dose may need to go up as you progress through your treatment plan. Your price won't.

HSA and FSA accounts cover PlexusDx semaglutide therapy, making it accessible for budget-conscious patients. Combined with the optional Precision Peptide Genetic Test ($99 add-on), you gain personalized insights into your peptide pathways and potential response speed. This data-driven approach removes guesswork and helps you commit confidently to a timeline that matches your genetics and goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight can I expect to lose in the first month on semaglutide?

Most patients lose 2–5 pounds in the first 4 weeks as appetite decreases and calorie intake drops. Weight loss speed depends on starting dose, baseline weight, and dietary adherence. PlexusDx patients often report faster progress when combining medication with structured nutrition support.

Will weight loss continue after 3 months of semaglutide?

Yes. While the steepest weight loss typically occurs in months 2–6, research shows continued progress through month 12 and beyond with consistent therapy. Your body may reach a plateau temporarily, but adjusting dose or lifestyle factors usually restarts weight loss momentum.

What if I don't see weight loss after 4 weeks?

Non-response after one month is uncommon but possible if your dose is too low or if diet remains unchanged. PlexusDx recommends tracking appetite changes, portion sizes, and energy levels—often the first signs that semaglutide is working. If results plateau, a genetic test may reveal whether your GLP1R or GIPR variants require optimized dosing.

Is there a way to know if semaglutide will work well for me before starting?

PlexusDx Precision Peptide Genetic Test analyzes 49 peptides across 14 pathways, including GLP1R rs6923761 and GIPR rs1800437 variants that predict semaglutide response. This $99 test, taken after your first month, reveals whether your genetics favor rapid weight loss or suggest a different compound may work better.

How does PlexusDx semaglutide pricing work if my dose increases?

PlexusDx charges one flat monthly rate starting at $149—not per dose or per injection. Whether you start at 0.25 mg or increase to 1.0 mg over months, your price remains the same. This transparent model removes cost anxiety as your provider titrates your dose upward for optimal results.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves